IP Library Granted Patent US 10,835,379
Granted Patent B2
US 10,835,379 · App. 15/957,325 · Granted Nov 17, 2020

Method for performing single-stage cranioplasty reconstruction with a clear custom cranial implant

Inventors: Chad R. Gordon (Cockeysville, MD); Jesse Christopher (Hunt Valley, MD); Bradley Rabinovitz (Annapolis, MD)
Assignee: Longeviti Neuro Solutions LLC
A61F2/2875A61B17/688A61B17/8085A61B34/10A61B2034/105A61B2034/108A61F2/30942A61F2002/2882A61F2002/3009A61F2002/3096A61F2002/30617A61F2002/30948A61F2240/002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,835,379
App. No.
15/957,325
Granted
Nov 17, 2020
Kind
B2
Abstract

A method for single-stage cranioplasty reconstruction includes prefabricating a clear craniofacial implant, creating a cranial, craniofacial, and/or facial defect, positioning the clear craniofacial implant over the cranial, craniofacial, and/or facial defect, tracing cut lines on the clear craniofacial implant as it lies over the cranial, craniofacial, and/or facial defect, cutting the prefabricated clear custom craniofacial implant along the hand-marked lines for optimal fit of the clear implant within the cranial, craniofacial, and/or facial defect, and attaching the final clear craniofacial implant to the cranial, craniofacial, and/or facial defect with standard fixation methods of today.

Claims (42)

1. A method for performing a cranioplasty, comprising:

creating a cranial, craniofacial, and/or facial defect;

positioning a clear craniofacial implant over the cranial, craniofacial, and/or facial defect;

tracing cut lines defining a boundary of the cranial, craniofacial, and/or facial defect on the clear craniofacial implant, the implant fabricated based upon information generated by preoperative scans, wherein the step of positioning the clear craniofacial implant over the cranial, craniofacial, and/or facial defect is performed prior to the step of tracing cut lines and the step of tracing cut lines includes tracing cut lines on the clear craniofacial implant as the clear craniofacial implant lies over the cranial, craniofacial, and/or facial defect, wherein a boundary of the cranial, craniofacial, and/or facial defect is viewable through the clear craniofacial implant thereby allowing for visible tracing;

cutting the clear custom craniofacial implant along the traced cut lines for optimal fit of the craniofacial implant along the cranial, craniofacial, and/or facial defect; and

attaching the final clear craniofacial implant to the cranial, craniofacial, and/or facial defect.

2. The method according to claim 1 , wherein the clear craniofacial implant is composed of PMMA.

3. The method according to claim 1 , wherein the step of positioning includes placing the clear craniofacial implant over the cranial, craniofacial, and/or facial defect in a desired orientation based upon a unique anatomy of an outer surface of a skull surrounding the cranial, craniofacial, and/or facial defect.

4. The method according to claim 1 , wherein the step of tracing includes tracing a periphery of the cranial, craniofacial, and/or facial defect directly onto the clear craniofacial implant using a sterile intra-operative marking pen.

5. The method according to claim 1 , wherein the step of positioning includes placing the clear craniofacial implant over the cranial, craniofacial, and/or facial defect in a desired orientation based upon a unique anatomy of an outer surface of a skull surrounding the cranial, craniofacial, and/or facial defect which is visible through the clear craniofacial implant.

6. The method according to claim 5 , wherein the step of cutting includes trimming the clear craniofacial implant using medical grade tools, computer-assisted and/or robot-assisted devices in an operating room along boundaries defined by the traced cut lines.

7. The method according to claim 1 , wherein the step of cutting includes trimming the clear craniofacial implant using medical grade tools, computer-assisted and/or robot-assisted devices in an operating room along boundaries defined by the traced cut lines.

8. The method according to claim 1 , further including the steps of identifying a diseased portion associated with aberrant craniofacial and/or brain anatomy and generating a computer-readable reconstruction of a patient's anatomy associated with the diseased portion for the purpose of designing and fabricating the clear craniofacial implant.

9. The method according to claim 8 , wherein the step of creating a cranial, craniofacial, and/or facial defect includes cutting out a diseased portion of a skull to be replaced with the clear craniofacial implant.

10. The method according to claim 5 , wherein the step of creating a cranial, craniofacial, and/or facial defect includes cutting out a portion of a skull to be replaced with the clear craniofacial implant.

11. The method according to claim 5 , wherein a neurological device with constant or intermittent function is incorporated within the clear craniofacial implant.

12. The method according to claim 11 , further including the step of prefabricating the clear craniofacial implant, wherein prefabricating the clear craniofacial implant includes incorporating the neurological device within the clear craniofacial implant via 3D printing, liquid molding, vacuum assisted liquid molding, mechanically altered manufacturing methods, milling techniques, or combination thereof.

13. The method according to claim 11 , wherein the neurological device is a monitoring device or device for treating a neurological disorder.

14. The method according to claim 5 , wherein the cranioplasty is a single-stage cranioplasty.

15. The method according to claim 5 , wherein the clear craniofacial implant includes an etching or a marking.

16. The method according to claim 15 , further including the step of prefabricating the clear craniofacial implant, wherein prefabricating the clear craniofacial implant includes incorporating the etching or the marking via 3D printing, liquid molding, vacuum assisted liquid molding, mechanically altered manufacturing methods, milling techniques, or combination thereof.

17. The method according to claim 15 , wherein the etching or marking indicates a desired implanted orientation of the clear craniofacial implant.

18. The method according to claim 15 , wherein the etching or marking identifies anatomy beneath the defect, a tumor sight, an aneurysm location, or a functional component.

19. The method according to claim 15 , wherein the etching or marking identifies a prescription, a disease state, or a date of surgery, or type of implantable neurotechnology housed within the clear craniofacial implant.

20. The method according to claim 1 , wherein the clear craniofacial implant is sonolucent.

21. The method according to claim 1 , wherein the clear craniofacial implant is radiolucent.

22. A method for using a craniofacial implant, comprising:

creating a cranial, craniofacial, and/or facial defect;

positioning a clear craniofacial implant over the cranial, craniofacial, and/or facial defect;

tracing cut lines defining a boundary of the cranial, craniofacial, and/or facial defect on the clear craniofacial implant, the implant prefabricated based upon information generated by preoperative scans, wherein the step of positioning the clear craniofacial implant over the cranial, craniofacial, and/or facial defect is performed prior to the step of tracing cut lines and the step of tracing cut lines includes tracing cut lines on the clear craniofacial implant as the clear craniofacial implant lies over the cranial, craniofacial, and/or facial defect, wherein a boundary of the cranial, craniofacial, and/or facial defect is viewable through the clear craniofacial implant thereby allowing for visible tracing; and

cutting the clear custom craniofacial implant along the traced cut lines for optimal fit of the craniofacial implant along the cranial, craniofacial, and/or facial defect.

23. The method according to claim 22 , wherein the clear craniofacial implant is composed of PMMA.

24. The method according to claim 22 , wherein a neurological device with constant or intermittent function is incorporated within the clear craniofacial implant.

25. The method according to claim 24 , further including the step of prefabricating the clear craniofacial implant, wherein prefabricating the clear craniofacial implant includes incorporating the neurological device within the clear craniofacial implant via 3D printing, liquid molding, vacuum assisted liquid molding, mechanically altered manufacturing methods, milling techniques, or combination thereof.

26. The method according to claim 24 , wherein the neurological device is a monitoring device or device for treating a neurological disorder.

27. The method according to claim 22 , wherein the clear craniofacial implant includes an etching or a marking.

28. The method according to claim 27 , further including the step of prefabricating the clear craniofacial implant, wherein prefabricating the clear craniofacial implant includes incorporating the etching or the marking via 3D printing, liquid molding, vacuum assisted liquid molding, mechanically altered manufacturing methods, milling techniques, or combination thereof.

29. The method according to claim 27 , wherein the etching or marking indicates a desired implanted orientation of the clear craniofacial implant.

30. The method according to claim 27 , wherein the etching or marking identifies anatomy beneath the defect, a tumor sight, an aneurysm location, or a functional component.

31. The method according to claim 27 , wherein the etching or marking identifies a prescription, a disease state, or a date of surgery, or type of implantable neurotechnology housed within the clear craniofacial implant.

32. The method according to claim 22 , wherein the clear craniofacial implant is sonolucent.

33. The method according to claim 22 , wherein the clear craniofacial implant is radiolucent.

Assignments (4)
CHANGE OF NAME Recorded Jun 11, 2025
From: LONGEVITI NEURO SOLUTIONS LLC
To: LONGEVITI NEURO SOLUTIONS, INC.
Reel/Frame 071383/0020 →
PATENT SECURITY AGREEMENT Recorded May 12, 2025
From: LONGEVITI NEURO SOLUTIONS, INC.
To: SCOF BLOCKER AIV, L.P.
Reel/Frame 071280/0062 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S ADDRESS AND DOCKET NO. PREVIOUSLY RECORDED ON REEL 045590 FRAME 0614. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF ASSIGNORS INTEREST. Recorded Jan 9, 2019
From: GORDON, CHAD R., DR.; CHRISTOPHER, JESSE; RABINOVITZ, BRADLEY
To: LONGEVITI NEURO SOLUTIONS LLC
Reel/Frame 049347/0649 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2018
From: GORDON, CHAD R., DR.; CHRISTOPHER, JESSE; RABINOVITZ, BRADLEY
To: LONGEVITI NEURO SOLUTIONS LLC
Reel/Frame 045590/0614 →
Continuity (2)
Provisional Application 62489036 · Apr 24, 2017
Related Publication 20180325672A1 · Nov 15, 2018
Cited By (1)
US 12,678,287